ATLANTA — New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, found that most echocardiography screening for fetal congenital heart block in anti-Ro- and anti-La-positive pregnancies did not follow recommended guidelines in one academic medical center ( [Abstract #0957](#) ). Maternal anti-Ro/SSA and anti-La/SSB antibodies are associated with…
Read More
About The Author
